National HealthCare Corporation (NHC) Insider Trading Activity

AMEX$212.425+6.59 (3.20%)
Market Cap
$3.22B
Sector
Healthcare
Industry
Medical—Care Facilities
Rank in Sector
252 of 849
Rank in Industry
12 of 39

NHC Insider Trading Activity

NHC Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$174,859
1
5
Sells
$11,156,466
20
95

Related Transactions

Piercey Lisadirector
1
$174,859
0
$0
$174,859
Gifford David R.director
0
$0
1
$401,022
$-401,022
Flatt Stephen FowlerCEO
0
$0
2
$485,950
$-485,950
McCreary Josh ASenior VP & General Counsel
0
$0
1
$609,669
$-609,669
Shelly Timothy J.Sr.VP Operations
0
$0
2
$707,581
$-707,581
Dodson Vicki LSr.VP Patient Srvcs
0
$0
1
$1.09M
$-1.09M
LAROCHE RICHARD F JRdirector
0
$0
1
$1.46M
$-1.46M
KIDD BRIAN FSVP, CFO
0
$0
1
$1.54M
$-1.54M
FLATT BEN ANDERSON SRSenior VP & CIO
0
$0
7
$1.59M
$-1.59M
HASSAN EMIL Edirector
0
$0
4
$3.27M
$-3.27M

About National HealthCare Corporation

National HealthCare Corporation (NHC) is a prominent provider in the healthcare sector, involved in the operation, management, and service provision for a wide array of elder care and health facilities. Its diverse portfolio includes skilled nursing facilities, assisted living communities, independent living residences, homecare and hospice agencies, and a specialized behavioral health hospital. Within its skilled nursing environments, NHC offers extensive therapeutic and medical care. Patients recovering from conditions such as strokes, heart …

Insider Activity of National HealthCare Corporation

Over the last 12 months, insiders at National HealthCare Corporation have bought $174,859 and sold $11.16M worth of National HealthCare Corporation stock.

On average, over the past 5 years, insiders at National HealthCare Corporation have bought $411,544 and sold $5.1M worth of stock each year.

Highest buying activity among insiders over the last 12 months: Piercey Lisa (director) — $174,859.

The last purchase of 949 shares for transaction amount of $174,859 was made by Piercey Lisa (director) on 2026‑06‑01.

List of Insider Buy and Sell Transactions, National HealthCare Corporation

2026-09-22SaleDodson Vicki LSr.VP Patient Srvcs
4,834
0.0314%
$225.00
$1.09M
+1.71%
2026-09-11SaleKIDD BRIAN FSVP, CFO
6,813
0.0439%
$225.70
$1.54M
+0.61%
2026-09-10SaleMcCreary Josh ASenior VP & General Counsel
2,719
0.0174%
$224.23
$609,669
+0.30%
2026-08-28SaleFLATT BEN ANDERSON SRSenior VP & CIO
1,000
0.0064%
$222.50
$222,500
+0.97%
2026-08-25SaleFLATT BEN ANDERSON SRSenior VP & CIO
1,000
0.0065%
$227.00
$227,000
+0.05%
2026-08-25SaleGifford David R.director
1,779
0.0114%
$225.42
$401,022
+0.05%
2026-08-20SaleFLATT BEN ANDERSON SRSenior VP & CIO
1,000
0.0064%
$237.00
$237,000
-5.02%
2026-08-19SaleFlatt Stephen FowlerCEO
1,500
0.0097%
$237.08
$355,620
-3.92%
2026-08-19SaleFLATT BEN ANDERSON SRSenior VP & CIO
1,000
0.0065%
$237.18
$237,180
-3.92%
2026-08-17SaleFLATT BEN ANDERSON SRSenior VP & CIO
1,000
0.0063%
$226.00
$226,000
-1.44%
2026-08-14SaleFLATT BEN ANDERSON SRSenior VP & CIO
1,000
0.0064%
$222.11
$222,110
+0.63%
2026-08-12SaleFLATT BEN ANDERSON SRSenior VP & CIO
1,000
0.0064%
$221.21
$221,210
+1.47%
2026-06-22SaleHASSAN EMIL Edirector
5,937
0.0377%
$200.00
$1.19M
+11.01%
2026-06-16SaleHASSAN EMIL Edirector
1,563
0.0104%
$199.97
$312,561
+16.41%
2026-06-01PurchasePiercey Lisadirector
949
0.0062%
$184.26
$174,859
+23.94%
2026-05-21SaleLAROCHE RICHARD F JRdirector
7,500
0.0478%
$195.14
$1.46M
+13.37%
2026-05-19SaleShelly Timothy J.Sr.VP Operations
1,853
0.0119%
$197.22
$365,444
+13.25%
2025-12-17SaleShelly Timothy J.Sr.VP Operations
2,454
0.0157%
$139.42
$342,137
+37.86%
2025-11-25SaleHASSAN EMIL Edirector
7,500
0.0513%
$138.52
$1.04M
+37.46%
2025-11-21SaleFlatt Stephen FowlerCEO
1,000
0.0064%
$130.33
$130,330
+45.16%
Total: 283
*Gray background shows transactions not older than one year

Insider Historical Profitability

24.68%
LAROCHE RICHARD F JRdirector
205760
1.3138%
$42.35M511
+28.79%
HASSAN EMIL Edirector
65595
0.4188%
$13.5M324
+9.32%
Piercey Lisadirector
949
0.0061%
$195,332.6710
DANIEL DONALD Kformerly Sr.VP, Controller
186456
1.1905%
$38.38M10
<0.0001%
Ussery Robert MichaelPresident & COO
144831
0.9248%
$29.81M13
+40.32%
BURGESS ERNEST G IIIdirector
83000
0.53%
$17.08M124
+28.31%
ADAMS W ANDREWdirector
42851
0.2736%
$8.82M40
+32.71%
ABERNATHY JAMES PAULdirector
33278
0.2125%
$6.85M161
+15.71%
ADAMS ROBERT Gdirector
3034
0.0194%
$624,488.2220
+35.8%
DENBESTEN KENNETH DSenior Vice President, Finance
0
0%
$0111
+14.49%
*Gray background shows insiders who have made transactions during last year

NHC Institutional Investors: Active Positions

Increased Positions106+44.73%762,983+7.98%
Decreased Positions100-42.19%353,555-3.7%
New Positions34New116,174New
Sold Out Positions21Sold Out104,785Sold Out
Total Postitions243+2.53%10M+4.28%

NHC Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Blackrock, Inc.$245,550.0011.77%1.88M-23,433-1.23%2025-09-30
Vanguard Group Inc$185,469.008.89%1.42M-19,005-1.32%2025-09-30
Dimensional Fund Advisors Lp$125,919.006.04%965,565-4,297-0.44%2025-09-30
Morgan Stanley Institutional Investment Advisors Llc$97,706.004.68%749,221-2,944-0.39%2025-09-30
State Street Corp$63,983.003.07%490,632-2,033-0.41%2025-09-30
M Holdings Securities, Inc.$60,405.002.9%463,194+463,194New2025-09-30
Renaissance Technologies Llc$48,756.002.34%373,867-13,600-3.51%2025-09-30
Geode Capital Management, Llc$41,220.001.98%316,079+5,332+1.72%2025-09-30
First Trust Advisors Lp$27,058.001.3%207,483+175,873+556.38%2025-09-30
Charles Schwab Investment Management Inc$24,647.001.18%189,000+6,348+3.48%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

No data is available at this moment.
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.